Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biochemical Recurrence of Malignant Neoplasm of Prostate”

85 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 85 results

Not applicableStudy completedNCT03087903
What this trial is testing

Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA

Who this might be right for
Prostate Cancer
University of Colorado, Denver 41
Testing effectiveness (Phase 2)Study completedNCT02649439
What this trial is testing

Prostvac in Patients With Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 97
Large-scale testing (Phase 3)UnknownNCT03119857
What this trial is testing

Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14

Who this might be right for
Prostatic Neoplasms
Göteborg University 349
Testing effectiveness (Phase 2)Looking for participantsNCT04700332
What this trial is testing

PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Hoag Memorial Hospital Presbyterian 184
Large-scale testing (Phase 3)Ended earlyNCT00236002
What this trial is testing

Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )

Who this might be right for
Osteoporosis
Canadian Urology Research Consortium 182
Testing effectiveness (Phase 2)Study completedNCT00551525
What this trial is testing

Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT03637543
What this trial is testing

Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Beth Israel Deaconess Medical Center 29
Not applicableLooking for participantsNCT07538843
What this trial is testing

An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment

Who this might be right for
Non-metastatic Castration-resistant Prostate Cancer
Bayer 800
Testing effectiveness (Phase 2)WithdrawnNCT04585932
What this trial is testing

Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Prostate CarcinomaOligometastatic Prostate Carcinoma+3 more
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT00379561
What this trial is testing

PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Sophiris Bio Corp 24
Testing effectiveness (Phase 2)Study completedNCT04335682
What this trial is testing

Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide

Who this might be right for
Metastatic Prostate CancerProstate Cancer MetastaticProstate Cancer+3 more
Alliance Foundation Trials, LLC. 111
Testing effectiveness (Phase 2)Study completedNCT00239291
What this trial is testing

Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer

Who this might be right for
Non-Metastatic Prostate Cancer
AstraZeneca 42
Large-scale testing (Phase 3)Study completedNCT01006395
What this trial is testing

Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)

Who this might be right for
Prostate Cancer
Austin Health 64
Not applicableStudy completedNCT04049747
What this trial is testing

Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer

Who this might be right for
Prostate CancerNon-metastatic Prostate CancerProstate Adenocarcinoma
Imperial College London 100
Not applicableUnknownNCT03948204
What this trial is testing

Quality of Life and Shared Decision Making in Prostate Cancer

Who this might be right for
Prostate Cancer
Norwegian Institute of Public Health 10,000
Testing effectiveness (Phase 2)Ended earlyNCT00814892
What this trial is testing

Vaccine Therapy in Treating Patients With Non-Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Mayo Clinic 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT04206319
What this trial is testing

Radium-223 in Biochemically Recurrent Prostate Cancer

Who this might be right for
Biochemical Recurrent Prostate Cancer
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT03315871
What this trial is testing

Combination Immunotherapy in Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT05617885
What this trial is testing

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

Who this might be right for
Metastatic Prostate CancerNon-metastatic Prostate CancerProstate Cancer
Praful Ravi, MB BCHir, MRCP 9
Testing effectiveness (Phase 2)Temporarily pausedNCT04519879
What this trial is testing

White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA

Who this might be right for
Prostate AdenocarcinomaPSA FailurePSA Progression+7 more
City of Hope Medical Center 133
Next Page